Log In
Print this Print this

Acellular pertussis vaccine

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationPertussis
Indication DetailsPrevent diphtheria, tetanus and pertussis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today